High levels of ammonia in tumors leads to fewer T cells and immunotherapy resistance in mouse models of colorectal cancer, new findings revealed. Researchers found that ammonia inhibits the growth and function of T cells, which are vital for anti-tumor immunity. The findings appear in Cell Metabolism.
“We identified the mechanism of how ammonia dysregulates T cell function and showed that reducing ammonia levels using FDA-approved drugs for hyperammonemia can reduce tumor size in several different models including metastatic colorectal cancer,” says an author on this paper. “Use of this drug also synergizes with immunotherapy. If you treat the mice with immunotherapy when you also treat them with this ammonia reducing agent, you're able to sensitize the tumors to treatment.”
“Most colorectal cancers are insensitive to immune therapies,” adds the first author of the study. “We’ve found that one of the mechanisms that leads to this resistance is likely the high level of ammonia that accumulates in the microenvironment.”
The author explains that while there are many factors that contribute to immunotherapy resistance, there are few therapeutic interventions that can reactivate therapy sensitivity. “Our study shows that this is a relatively safe and FDA-approved method that could work alongside immunotherapy to make treatment more effective for patients. This new method provides a potentially direct avenue to treat tumors and reactivate the immune system.”
How does ammonia accumulate in colorectal tumors in the first place? Ammonia levels are regulated by a balance of production and cellular detoxification. Most ammonia is generated by the microbiota, but this work suggests that increased production of ammonia is not what results in accumulation. “Our work demonstrates that tumors have lost the ability to detoxify ammonia leading to build up,” said the author.
Further, the accumulation of ammonia is likely not isolated to just colorectal tumors. The author says this discovery may open doors in explaining resistance to other cancer types as well. “Only about 20-30% of all cancer patients are sensitive to immunotherapy. 70% of patients don’t derive any benefit from it,” the author said. “Now, we have a mechanism that could explain this resistance in tumors beyond colon cancer.”
More work needs to be done before researchers can bring these findings into the clinic.
https://www.cell.com/cell-metabolism/fulltext/S1550-4131(22)00504-6
High levels of ammonia in colon tumors inhibits T cell growth and response to immunotherapy
- 990 views
- Added
Latest News
Alzheimer's disease symptom…
By newseditor
Posted 27 Jun
Gene-regulatory networks in…
By newseditor
Posted 27 Jun
How apoE influences Aβ aggr…
By newseditor
Posted 26 Jun
How do plants break down da…
By newseditor
Posted 26 Jun
A new tool for neurological…
By newseditor
Posted 26 Jun
Other Top Stories
Specific bacteria in the small intestine are crucial for fat absorp…
Read more
Variation in a gene affects how some women store fat – and ups thei…
Read more
Why alcohol, sugar lead to thirst
Read more
Why is it harder for females to gain weight?
Read more
Enduring cold temperatures alters fat cell epigenetics
Read more
Protocols
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
Publications
Immunometabolism in atheros…
By newseditor
Posted 27 Jun
Long-range inhibitory neuro…
By newseditor
Posted 27 Jun
The microtubule-dynamin bin…
By newseditor
Posted 27 Jun
High sugar diet-induced fat…
By newseditor
Posted 27 Jun
Brain repair mechanisms aft…
By newseditor
Posted 27 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar